Congratulations to the 3 experts of the China Pharmaceutical Innovation Promotion Association for being elected as academicians of the two academies

On November 18, the results of the 2021 co-election of academicians of the Chinese Academy of Sciences and the Chinese Academy of Engineering were announced
.

Congratulations to our vice president (2017-2018 president) Jiang Jiandong and member representative Xiao Wei for being elected as an academician of the Chinese Academy of Engineering, and Gu Ning, founder of the Medical Digital and Innovative Therapy Professional Committee, for being elected as an academician of the Chinese Academy of Sciences

Jiang Jiandong Researcher

Jiang Jiandong, doctoral supervisor, researcher of the Institute of Pharmaceutical Biotechnology, Chinese Academy of Medical Sciences, former director of the Institute of Materia Medica, Chinese Academy of Medical Sciences, 2017-2018 president of China Association for the Promotion of Pharmaceutical Innovation, current Vice President of China Association for the Promotion of Pharmaceutical Innovation, China Dean of the Institute of Materia Medica, Academy of Medical Sciences, editor-in-chief of Acta Pharmaceutica Sinica B, and member of the Academic Degrees Committee of the State Council
.

Jiang Jiandong has been engaged in the research of new antiviral, anti-metabolic diseases and anti-tumor drugs for a long time, and discovered new mechanisms and drugs for lowering blood lipid signaling pathways; discovered new antiviral mechanisms, targets and drugs that are difficult to cause drug resistance; developed new drugs Structured anti-tumor drug candidate
.

Published more than 90 papers on important international SCI journal Nature Medicine, Cancer Cell, Hepatology, PNAS, Cancer Research and so on

During his tenure as the president of our association, Jiang Jiandong led our association to continuously enrich the diversified membership organization structure, improve China's pharmaceutical innovation policy environment, give play to the leading effect of domestic innovative brands, broaden domestic and foreign pharmaceutical and investment cross-border cooperation channels, and promote openness, tolerance and wealth The vigorous capital market reform has been implemented steadily, leading our various work to a new level, and has achieved good results recognized by all sectors of society
.

During his tenure as vice president of our society, Jiang Jiandong actively made suggestions for various work of our society, carefully guided our policy research and other related work, and made important contributions to the scientific and comprehensive work of our society

Researcher Xiao Wei

Xiao Wei, Doctor of Chinese Materia Medica, Researcher, Doctoral Supervisor, Chairman of Jiangsu Kangyuan Pharmaceutical Co.
, Ltd.
, Representative of the 11th, 12th, and 13th National People's Congress, currently Director of the State Key Laboratory of New Technology of Chinese Medicine Pharmaceutical Process, Director of the National and Local Joint Engineering Research Center for Intelligent Manufacturing of Chinese Patent Medicines, concurrently serving as an executive member of the National Pharmacopoeia Commission, vice president of the Chinese Society of Chinese Medicine, and an executive director of the Chinese Society of Integrative Medicine
.

Xiao Wei has devoted more than 30 years of research in the fields of new Chinese medicine drug creation, production process quality control, and intelligent manufacturing.
He has made significant contributions to improving China's Chinese patent medicine and natural medicine R&D and manufacturing technology level, and enjoys special government allowances from the State Council
.

As the chief scientist of "973", he won 1 second prize of National Technology Invention Award (ranked 1st), 2 second prizes of National Science and Technology Progress Award (ranked 1st and 2nd), and 5 first prizes of Provincial and Ministerial Science and Technology Progress Award (both Ranking 1); Won the Heliang Heli Foundation Science and Technology Innovation Award, Guanghua Engineering Science and Technology Award; Won the National Innovation Competition Award, the National May 1st Labor Medal, and the National Outstanding Scientific and Technological Worker

Professor Gu Ning

Gu Ning, born in May 1964, is the chief professor and doctoral supervisor of Southeast University
.

Selected by the Ministry of Education's Important Talent Project, National Outstanding Youth, and the 7th National Outstanding Scientific and Technological Worker

Gu Ning has been engaged in the research of nano-medical materials for a long time, and has made systematic contributions in innovative research on the preparation, characterization and biological effects of medical high-performance iron-based nanomaterials and phospholipid materials.
Two basic materials, the construction of an integrated diagnosis and treatment material system represented by magnetic microbubbles; the invention of new methods such as the magnetic internal heating method and the measurement of the magnetic moment image method of micro-nano particles in the liquid phase.
Enzyme effect and clarification of the mechanism, developed and approved the national standard material for medical nano-iron oxide relaxation rate and the national standard for enzyme-like activity determination; developed high-performance medical magnetic micro-nano materials, which have been widely used in nucleic acid transfection and protein separation, The research and development of new products such as chemiluminescence detection and clinical diagnosis; the research and development of polysaccharide superparamagnetic iron oxide intravenous injection, clinical research can be used for magnetic resonance image enhancement in addition to iron supplementation, laying the foundation for a new generation of magnetic resonance contrast agents; innovative synthesis Phospholipid preparation and drug delivery technology, the development of high-purity synthetic phospholipids has been filed by the National Medical Examination Center, supporting the establishment of the only domestic company that can produce and provide synthetic phospholipids.
Phospholipid materials have been used in the research and development of high-end preparations by many domestic and foreign research institutions and pharmaceutical companies
.

He has published more than 500 papers in SCI journals, cited more than 10,000 times in front of him, edited three books, and authorized more than one hundred invention patents
.

Won the second prize of National Natural Science, the second prize of National Science and Technology Progress, the first prize of Natural Science of Higher Education Ministry of Education, the first prize of Science and Technology of Jiangsu Province, the 46th "Geneva International Invention Exhibition" Chartered Gold Award and other scientific and technological awards

In the future, with the help and guidance of more and more academicians of the Chinese Academy of Sciences and Chinese Academy of Sciences, we will continue to contribute to the sustainable development of my country's pharmaceutical innovation, the protection of people's health, and the realization of my country's great goal of becoming a medical power!